1. Home
  2. IOVA vs NEOG Comparison

IOVA vs NEOG Comparison

Compare IOVA & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • NEOG
  • Stock Information
  • Founded
  • IOVA 2007
  • NEOG 1981
  • Country
  • IOVA United States
  • NEOG United States
  • Employees
  • IOVA N/A
  • NEOG N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • IOVA Health Care
  • NEOG Health Care
  • Exchange
  • IOVA Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • IOVA 3.0B
  • NEOG 3.2B
  • IPO Year
  • IOVA N/A
  • NEOG 1989
  • Fundamental
  • Price
  • IOVA $8.18
  • NEOG $14.60
  • Analyst Decision
  • IOVA Strong Buy
  • NEOG Hold
  • Analyst Count
  • IOVA 9
  • NEOG 1
  • Target Price
  • IOVA $23.33
  • NEOG $17.50
  • AVG Volume (30 Days)
  • IOVA 7.2M
  • NEOG 1.4M
  • Earning Date
  • IOVA 11-07-2024
  • NEOG 01-07-2025
  • Dividend Yield
  • IOVA N/A
  • NEOG N/A
  • EPS Growth
  • IOVA N/A
  • NEOG N/A
  • EPS
  • IOVA N/A
  • NEOG N/A
  • Revenue
  • IOVA $90,858,000.00
  • NEOG $912,199,000.00
  • Revenue This Year
  • IOVA $13,827.67
  • NEOG $3.38
  • Revenue Next Year
  • IOVA $183.70
  • NEOG $4.87
  • P/E Ratio
  • IOVA N/A
  • NEOG N/A
  • Revenue Growth
  • IOVA 12751.20
  • NEOG N/A
  • 52 Week Low
  • IOVA $4.44
  • NEOG $11.46
  • 52 Week High
  • IOVA $18.33
  • NEOG $20.89
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 32.59
  • NEOG 45.25
  • Support Level
  • IOVA $9.31
  • NEOG $14.21
  • Resistance Level
  • IOVA $10.86
  • NEOG $16.79
  • Average True Range (ATR)
  • IOVA 0.71
  • NEOG 0.67
  • MACD
  • IOVA -0.37
  • NEOG 0.04
  • Stochastic Oscillator
  • IOVA 1.48
  • NEOG 24.22

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Share on Social Networks: